Synthetic Biology for New Antibiotics
The antibiotic odilorhabdin has the potential to be used against resistant bacteria. However, the production yield in bacteria has been far too low. Scientists led by Prof. Dr. Helge Bode have now elucidated the biosynthesis pathway and created the basis for future synthetic and biological production of the antibiotic.
First Integration of Genetics and Metabolism in a Cell-free System
A milestone in Synthetic Biology: Dr Simone Giaveri from Prof Dr Tobias Erb's research group has succeeded in coupling a genetic and a metabolic network in vitro. The results, published in the current issue of the journal Science, are a first step towards self-sustaining cell-free systems.
A Microbial Approach to Controlling Crop Losses in Agriculture
Prof. Dr Helge Bode receives new ERC funding to develop biological alternatives for crop protection
Georg Hochberg receives the „ZukunftsWissen“ Award
Dr Georg Hochberg's work on the evolution of proteins can help to better understand and optimise biochemical processes such as photosynthesis in the laboratory. He has now been awarded the "ZukunftsWissen" prize, which is being awarded for the first time this year by the German Academy of Sciences Leopoldina and the Commerzbank Foundation.
Max Planck Children`s University at MPI-TM
On 27 June, we had the great pleasure of welcoming over 200 school kids to the institute. After an exciting lecture, they set off in search of special bacteria.
